Alumis, Inc. (ALMS)
6.31
+0.25
(+4.13%)
USD |
NASDAQ |
Oct 15, 16:00
6.30
-0.01
(-0.16%)
After-Hours: 20:00
Alumis Cash from Operations (TTM) : -351.40M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -351.40M |
| March 31, 2026 | -376.25M |
| December 31, 2025 | -369.52M |
| September 30, 2025 | -372.38M |
| June 30, 2025 | -345.24M |
| March 31, 2025 | -291.17M |
| Date | Value |
|---|---|
| December 31, 2024 | -255.08M |
| September 30, 2024 | -214.04M |
| June 30, 2024 | -163.52M |
| March 31, 2024 | -139.57M |
| December 31, 2023 | -129.98M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Johnson & Johnson | -- |
| Corcept Therapeutics, Inc. | 109.70M |
| Aclaris Therapeutics, Inc. | -62.06M |
| BioAge Labs, Inc. | -87.60M |
| ANI Pharmaceuticals, Inc. | 189.47M |